This HTML5 document contains 120 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://dx.doi.org/10.1038/
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q61150129
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована у квітні 2011 im April 2011 veröffentlichter wissenschaftlicher Artikel scientific article published on 15 April 2011 artículu científicu espublizáu n'abril de 2011 wetenschappelijk artikel
p:P577
wds:Q61150129-83009712-A24E-464F-8B82-D9C8C66A3F03
wdt:P577
2011-04-15T00:00:00Z
p:P2888
wds:Q61150129-4A9FA595-5310-4907-914E-853C51EC712F
wdt:P2888
n12:leu.2011.71
p:P2860
wds:Q61150129-BA63E2AF-A9BA-4ED5-BCD5-31FAB93BF2AA wds:Q61150129-BBB6603A-F99F-460F-808E-380C8E64B5C8 wds:Q61150129-C5956DF6-459C-4AED-936E-ADD2D1C0065E wds:Q61150129-C82306FC-EA98-401F-A16A-CB0763F123EE wds:Q61150129-AB737C0C-4840-401E-95BD-864F06BE2E4C wds:Q61150129-E14A85DB-11CA-4BD3-80A9-5C5FA3286DCA wds:Q61150129-E50D138A-7A0E-41A4-8B04-ADEE9CA74F6A wds:Q61150129-D38E1882-C4EB-4493-B936-483BF3C6BA9F wds:Q61150129-DC8C1B3C-6853-4E3D-B448-5187B92FCE14 wds:Q61150129-FA7A2F58-9CF2-494A-9303-624151460A23 wds:Q61150129-E5FBF579-A748-46D0-99FD-2DDF46EE6867 wds:Q61150129-1E763360-3568-4D23-AA07-DCB4060CF766 wds:Q61150129-300DC12E-7F1F-4B32-B647-F7B836A34932 wds:Q61150129-116825BD-ECA4-4150-A524-A1855D97FF02 wds:Q61150129-473F6AD1-C3A2-4841-B65C-B17AE4AC4B1F wds:Q61150129-572DC9E1-44E8-467F-BBCA-D863351F6966 wds:Q61150129-3548148E-0034-445A-86E0-ADE4816A796E wds:Q61150129-37F3DE67-BEDC-49D9-A0B0-A37D75468138 wds:Q61150129-6B972602-A133-423F-B892-B42B0F236EDD wds:Q61150129-781E9B6C-90A6-4729-BC37-025A6B3D7AC1 wds:Q61150129-79DCE063-1CFA-4F9E-9356-4E97E444E01D wds:Q61150129-664A01A5-D43F-44F3-A2BC-ADEA05B86D17 wds:Q61150129-678A01C5-A890-4C95-BBB7-514B7101F825 wds:Q61150129-98473E4C-AD95-431D-92EC-6F5B3DD3B6F6 wds:Q61150129-9E6A4493-FDD7-47A4-A284-045396FDC403 wds:Q61150129-7FD4DA93-340C-4351-9A73-36B0318B6968 wds:Q61150129-85F2E876-E3F8-4B14-ACD2-5CD0D5494F9E
wdt:P2860
wd:Q24316558 wd:Q34615087 wd:Q37372837 wd:Q34585579 wd:Q38343881 wd:Q33841988 wd:Q34088756 wd:Q24306181 wd:Q37262428 wd:Q27851480 wd:Q34984094 wd:Q29614510 wd:Q33628772 wd:Q50558385 wd:Q28275931 wd:Q58865927 wd:Q34559054 wd:Q45088115 wd:Q37341297 wd:Q33891633 wd:Q24563021 wd:Q37723835 wd:Q34128471 wd:Q29619292 wd:Q80568676 wd:Q38487533 wd:Q28504641
p:P2093
wds:Q61150129-B13BF741-6051-47E5-BC69-583B8ADC1D51 wds:Q61150129-B3A27710-3576-4D60-BBD4-8CD9DBA15121 wds:Q61150129-31DBD86A-BCBC-4461-864F-683D7D6AB5E0 wds:Q61150129-6707D606-7151-4685-B970-257CF080948E wds:Q61150129-1DAAF337-B7EF-4E0B-B645-FBB94AC5590F wds:Q61150129-E2720368-8633-44D5-980B-3506A9619947
wdt:P2093
V Mansat-De Mas N Vey S Raynaud F Dreyfus L Adès T Cluzeau
rdfs:label
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
skos:prefLabel
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
schema:name
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
p:P50
wds:Q61150129-2BBF36DD-982B-486C-97F9-C5C2165C40EC wds:Q61150129-A152B5C6-916A-4BAC-A414-E010053ABC9B wds:Q61150129-96D70A60-E92F-415A-8E35-4C78BA4284BD wds:Q61150129-6D5BD990-0DE4-4E42-ADB5-9F69B2431174 wds:Q61150129-36414EE4-7E07-4586-88C1-E0C1321DE744 wds:Q61150129-F50568A4-ABEF-48AB-AEBC-31B09989C37C wds:Q61150129-F631A1B3-0D65-41D3-AC94-DF172265A19C wds:Q61150129-D501DCB5-CE53-4A69-9BDD-F42CC3C6497F wds:Q61150129-E313A1A9-4AA9-4C6C-A964-06F06F24478F
wdt:P50
wd:Q30170087 wd:Q40319340 wd:Q56959029 wd:Q37393688 wd:Q59202821 wd:Q30170095 wd:Q114426329 wd:Q42399938 wd:Q42231573
p:P1476
wds:Q61150129-046DB09A-CAC2-44E2-8EC7-B48CF8B81C34
wdt:P1476
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
p:P304
wds:Q61150129-A0EF2D2C-F4EA-419B-A2E0-D7DFA1A47FF1
wdt:P304
1147-1152
p:P31
wds:Q61150129-E135531A-42E4-4EB9-A6AD-57F1A454A80F
wdt:P31
wd:Q13442814
p:P698
wds:Q61150129-60FE0114-E53B-4198-A2CC-8507CE6491AA
wdtn:P698
n13:21494260
wdt:P698
21494260
p:P1433
wds:Q61150129-89C089B7-3DF3-48A7-847C-B22B609745B3
wdt:P1433
wd:Q6534498
p:P433
wds:Q61150129-EA019F38-4564-4408-904E-CFBD8ECC2A1C
p:P478
wds:Q61150129-4BDD4BDE-069C-497D-B33A-37A32051A74E
wdt:P433
7
wdt:P478
25
p:P356
wds:Q61150129-E971CE3A-E731-450F-BB07-02B046F53487
wdtn:P356
n9:LEU.2011.71
wdt:P356
10.1038/LEU.2011.71
p:P6179
wds:Q61150129-1D0F64DF-3457-4DEA-AAAD-4B1CBC13A200
wdt:P6179
1005713196